TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
JK Biostatistics AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,207
|
2,882
|
2,806 |
| Financial expenses |
12
|
1
|
3 |
| Earnings before taxes |
5
|
155
|
516 |
| EBITDA |
31
|
188
|
519 |
| Total assets |
1,891
|
2,155
|
1,448 |
| Current assets |
1,694
|
1,753
|
1,267 |
| Current liabilities |
499
|
757
|
241 |
| Equity capital |
1,392
|
1,398
|
1,207 |
| - share capital |
103
|
101
|
95 |
| Employees (average) |
2
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
73.6%
|
64.9%
|
83.4% |
| Turnover per employee |
1,104
|
961
|
935 |
| Profit as a percentage of turnover |
0.2%
|
5.4%
|
18.4% |
| Return on assets (ROA) |
0.9%
|
7.2%
|
35.8% |
| Current ratio |
339.5%
|
231.6%
|
525.7% |
| Return on equity (ROE) |
0.4%
|
11.1%
|
42.8% |
| Change turnover |
-727
|
-123
|
289 |
| Change turnover % |
-25%
|
-4%
|
11% |
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-33%
|
0%
|
50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.